The 100% rate on imported, branded pharma products will not apply to drugmakers constructing manufacturing facilities in the ...

Lithuania is rapidly growing as a leading force in the European life sciences scene, with over 400 life sciences companies in ...

Eli Lilly and Novo Nordisk are in a tight race to capture the lucrative oral obesity drug market – but how will their ...

Synaffix has entered a licensing agreement with South Korean biopharmaceutical firm Qurient to develop a dual-payload ADC.

Lilly has received approval from the US Food and Drug Administration (FDA) for Inluriyo (imlunestrant) to treat advanced ...

Tylenol’s label change plus leucovorin's approval offer a taster to the Trump administration’s plans to crack down on the US ...

AstraZeneca has launched an online direct-to-consumer (DTC) medicine platform in the US, joining a growing list of companies ...

Mérieux Equity Partners has outlined its approach to investing in Lithuania and wider Europe, highlighting a particular focus ...

Evaxion’s preclinical asset targets an unknown infectious disease in which there are no other vaccines available.

After demonstrating that its gene therapy can slash Huntington's disease progression by 75%, Uniqure will now file for ...

Patients will now be able to access BMS' Sotyktu for significantly cheaper than current list prices, alongside BMS and Pfizer ...

Moderna has opened its new vaccine manufacturing and R&D facility in Oxfordshire, UK, the Moderna Innovation and Technology ...